Remember, if it sounds too good to be true, it probably is
Round 2 was open from 10 to 20 October 2025
Presented for research literature review only Marchiafava PL et al
Baron JA (2003) Epidemiology of non-steroidal anti-inflammatory drugs and cancer
Thymosin-4derived peptides (TB-500) further contribute by regulating macrophage and neutrophil dynamics during tissue repair and infection, supporting controlled recruitment of innate immune cells and facilitating transition toward resolution-phase healing (33,34)
MT-II was designed and characterised through the systematic melanocortin peptide structure-activity relationship programme in Victor Hrubys laboratory at the University of Arizona , the same programme that produced MT-1 , with the cyclisation strategy introduced to further constrain the pharmacophore into a receptor-binding conformation that simultaneously increases potency, metabolic stability, and the receptor subtype selectivity profile that distinguishes MT-II from the linear tridecapeptide MT-1